Molecular testing for endocrine tumor diagnoses
Part of Cancer, Hormones & metabolism clinical trials.
This study collects and analyzes molecular (cell/DNA-level) information from endocrine tumors or pre-cancer conditions. It may help doctors better understand these tumors and improve diagnosis and treatment planning when you need surgery or a biopsy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have an endocrine-related growth or pre-cancer condition (for example thyroid, parathyroid, adrenal, pancreas, paraganglioma, or related tumors).
- Your condition has been found on scans and blood/biochemistry tests, or confirmed by biopsy or cytology (cell sample).
- You are planning to have surgery or a biopsy as part of standard care (they are not doing biopsies just for samples).
- Your overall functioning is fairly good (ECOG score 0 to 2).
- You meet basic physical exam safety requirements before the planned biopsy or surgery.
- You must be at least 4 years old.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects tumor (or related) samples to analyze their genes and build a shared research “biobank.” It may help researchers understand cancers better for future diagnosis and treatments.
This study looks at genetic (DNA) changes in people with pheochromocytoma or paraganglioma and related conditions. It may help clarify why these conditions happen and how they run in families.
This study looks at neuroendocrine tumors by collecting tissue (when available) and tracking how the disease behaves over time. It may help researchers better understand these cancers, including rare cases of adrenocortical cancer.
This study looks at your tumor’s genetic information to help doctors recommend treatment for cancers that have spread. It may help you get the most suitable therapy based on what’s found in your tumor.
This study aims to find genetic causes of neuroendocrine tumors in Mexican patients. By understanding your DNA, researchers hope to improve diagnosis and treatment for people with these rare conditions.
This trial uses special lab tests to look for tumor “molecular fingerprints” in your tumor or blood sample. The goal is to help your care team choose more personalized treatment options based on those results.
Hear when a new Parathyroid Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.